Spyre Therapeutics, Inc. ($SYRE)
Burrows Scott L โ Chief Financial Officer
Shares
2,500
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 26, 2026
EPS:Est: -0.66
Transaction Details
| Insider | Burrows Scott L |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Mar 3, 2026 |
| Expiration Date | Sep 1, 2033 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 4, 2026 |
| Shares Purchased | 2,500 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 402,357 |
| Derivative | Derivative |
| Accession Number | 0001636282-26-000028 |
| Document | View SEC Filing |